Puma Biotechnology, Inc. (NASDAQ:PBYI) Q3 2024 Earnings Call Transcript
Operator: Good afternoon. My name is Rob, and I'll be your conference call operator today. At this time, all participants are in listen-only mode.
Puma Biotechnology Inc. (PBYI)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Millennium Management Israel Englander | 1,894,126 | $5,777,084 | -35% | 0% |
| 2. | Renaissance Technologies Jim Simons | 1,755,513 | $5,354,315 | -1% | 0% |
| 3. | Eversept Partners Kamran Moghtaderi | 996,102 | $3,038,111 | -23% | 0.26% |
| 4. | D E Shaw D. E. Shaw | 222,608 | $678,954 | +288% | 0% |
| 5. | Tang Capital Management Kevin C. Tang | 200,000 | $610,000 | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $82.49 | 28 | Officer | 30 | 2014-04-11 | Filing | |
| $87.35 | 2 | Officer | 2 | 2014-04-09 | Filing | |
| $38.92 | 22,549 | Large Shareholder | 5,686,668 | 2013-11-08 | Filing | |
| $39.60 | 280,700 | Large Shareholder | 5,664,119 | 2013-11-05 | Filing | |
| $40.08 | 54,200 | Large Shareholder | 5,383,419 | 2013-10-09 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.15 | 10,227 | Officer | 152,295 | 2025-01-02 | Filing | |
| $3.15 | 9,437 | Officer | 108,951 | 2025-01-02 | Filing | |
| $3.15 | 8,633 | Officer | 124,594 | 2025-01-02 | Filing | |
| $3.15 | 33,841 | Large Shareholder, Officer, Director | 7,029,674 | 2025-01-02 | Filing | |
| $3.49 | 23,358 | Director | 47,000 | 2024-08-12 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 2,450,711 | $12,017,159 | 6.49% | |
| 2. | 3,823,805 | $11,662,606 | 0% | |
| 3. | 3,643,422 | $11,112,437 | 0% | |
| 4. | 948,376 | $2,892,546 | 0% | |
| 5. | 919,435 | $2,804,667 | 0% |
News See All
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q2 2024 Earnings Call Transcript
Operator: Good afternoon. My name is Diego and I will be your conference call operator today. [Operator Instructions] As a reminder, this conference call is being recorded.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.16.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript
Puma Biotechnology, Inc. misses on earnings expectations. Reported EPS is $0.26 EPS, expectations were $0.37. Puma Biotechnology, Inc.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q3 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Camilla, and I will be your conference call operator today. [Operator Instructions] As a reminder, this call is being recorded.
5 Best Quality Penny Stocks to Buy
Chimerix, Inc. (NASDAQ:CMRX) is working on treatments for fatal diseases. Chimerix, Inc.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q2 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Victoria, and I will be your conference call operator today. At this time, all participants are in a listen-only mode.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2023 Earnings Call Transcript
Operator: Good afternoon. My name is Rob, and I will be your conference call operator today. As a reminder, this call is being recorded.
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2022 Earnings Call Transcript
Operator: Good afternoon. My name is Diego, and I will be your conference call operator today. As a reminder, this call is being recorded.
5 Most Promising Cancer Stocks According to Analysts
BeiGene, Ltd. (NASDAQ:BGNE) is a Massachusetts-based biotechnology company that focuses on discovering, developing, and commercializing medicines worldwide.
Billionaire Hedge Funds
